FDA Inspection
Massachusetts General HospitalMassachusetts General Hospital – FDA Inspection, May 14, 2013
Record Details
This FDA Inspection record concerns Massachusetts General Hospital, with an inspection on May 14, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 14, 2013
- Product Type
- Biologics
View Company Profile
ID · f458c663-2f56-49ed-b22c-e7b44a502295
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 833328
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Massachusetts General Hospital
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Massachusetts General Hospital
- FDA Inspection 563761 - 2009-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.